<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392078</url>
  </required_header>
  <id_info>
    <org_study_id>LAANTERN</org_study_id>
    <nct_id>NCT02392078</nct_id>
  </id_info>
  <brief_title>Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System</brief_title>
  <acronym>LAANTERN</acronym>
  <official_title>Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monteris Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Monteris Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is
      being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS
      has been used in over 2600 procedures conducted at over 70 leading institutions across United
      States. This is a prospective, multi-center registry that will include data collection up to
      5 years to evaluate safety, QoL, and procedural outcomes including local control failure
      rate, progression free survival, overall survival, and seizure freedom in up to 1,000
      patients and up to 50 sites.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety (Reportable adverse events)</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Safety profile described by the NBS and surgical-related AEs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reason for NeuroBlate</measure>
    <time_frame>Index procedure</time_frame>
    <description>To identify the primary reason the NeuroBlate system was chosen for subject</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients demonstrating local control, overall survival, and seizure freedom (ENGEL and ILAE classifications)</measure>
    <time_frame>up to 12 months or last follow-up</time_frame>
    <description>Collected for all subjects by disease etiology.
Local control as measured by time to local tumor recurrence.
Overall survival assessed by Kaplan-Meier method.
Seizure freedom assessed for all subjects with epilepsy at time of last follow-up. The ENGEL surgical outcome scale is composed of four classes of epilepsy (Class I, Class II, Class III, Class IV) categorized by severity. The ILAE outcome scale contains six classes (Class 1, 2, 3, 4, 5, 6) categorized by severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>up to 12 months or last follow-up</time_frame>
    <description>Assessed by the following questionnaires:
KPS (subjects with CNS malignancy): Scale ranged 0-100 measuring the ability of patients with cancer to perform ordinary daily activities
FACT-Br (subjects with CNS malignancy): Measures general quality of life reflecting symptoms associated with brain malignancies across 5 scales (physical well-being social/family well-being, emotional well-being, functional well-being, and other)
EQ-5D (all subjects): A generic measure of health consisting of the descriptive system and the visual analogue scale (VAS). The descriptive system assesses subject mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The VAS reports the subject's self-rated health
QOLIE-31 (subjects with epilepsy): Contains 7 scales assessing emotional well-being, social functioning, energy/fatigue, cognitive functioning, seizure worry, medication effects, and overall quality of life for adults</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metastatic Brain Tumor</condition>
  <condition>Primary Brain Tumor</condition>
  <condition>Epileptic/Seizure Foci</condition>
  <condition>Movement Disorders</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NeuroBlate System</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who present with a brain lesion, epileptic/seizure foci, or movement disorder who
        have been deemed appropriate candidates, in the opinion of the treating physician, for
        laser ablation using the NeuroBlate® System.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject or legally authorized representative provides written authorization and/or
             consent

          2. Subject who is to undergo thermal therapy by the NeuroBlate® System for treatment of
             their neurological disorder

        Exclusion Criteria:

          1. Subject who is, or is expected to be inaccessible for follow-up

          2. Other concurrent medical or other condition (chronic or acute in nature) that in the
             opinion of the investigator, may prevent participation or otherwise render subject
             ineligibility for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Leuthardt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alyssa Griffeth</last_name>
    <phone>763-762-2733</phone>
    <email>agriffeth@monteris.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beth Larson-DeBruzzi</last_name>
    <phone>763-253-4710</phone>
    <phone_ext>2724</phone_ext>
    <email>bldebruzzi@monteris.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barrow Neurological Institute at Dignity Health St. Joseph's Hospital &amp; Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odilette Trevizo, RN, CNRN</last_name>
      <phone>602-406-1463</phone>
      <email>Odilette.Trevizo@DignityHealth.org</email>
    </contact>
    <investigator>
      <last_name>Kris Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lara Rose</last_name>
      <phone>858-822-6575</phone>
      <email>ljrose@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>David Piccioni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Hess</last_name>
      <phone>203-737-6259</phone>
      <email>judith.hess@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Veronica Chiang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advent Health Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brooke Hartwell</last_name>
      <phone>773-316-1514</phone>
      <email>Brooke.Hartwell@AdventHealth.com</email>
    </contact>
    <investigator>
      <last_name>James Baumgartner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Richardson</last_name>
      <phone>913-574-0412</phone>
      <email>lrichardson5@kumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Catherine Lauridsen</last_name>
      <phone>913-588-4573</phone>
      <email>clauridsen2@kumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Patrick Landazuri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Williford</last_name>
      <phone>502-852-7402</phone>
      <email>anna.williford@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Neimat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norton Cancer Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Ritchey</last_name>
      <phone>502-446-8544</phone>
      <email>debbie.ritchey@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>David Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Reid</last_name>
      <phone>612-624-7741</phone>
      <email>reidx121@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Clark Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United Children's Hospital St. Paul</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Ingram</last_name>
      <phone>612-813-6329</phone>
      <email>Katherine.Ingram@childrensmn.org</email>
    </contact>
    <investigator>
      <last_name>Jospeh Petronio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Haverman</last_name>
      <phone>314-747-1624</phone>
      <email>havermanr@mir.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Albert Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malcolm Delara</last_name>
      <phone>212-263-4414</phone>
      <email>malcolm.delara@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Ankeeta Joshi</last_name>
      <phone>212-263-4431</phone>
      <email>ankeeta.joshi@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Sylvia Kurz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ichan School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Adams</last_name>
      <phone>212-241-8349</phone>
      <email>Ryan.Adams@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Constantino Hadjipanayis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Huckins</last_name>
      <phone>315-464-8477</phone>
      <email>huckinss@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Zulma Tovar-Spinoza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Wimberly</last_name>
      <phone>919-681-9609</phone>
      <email>courtney.wimberly@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Fecci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Jenkins</last_name>
      <phone>336-716-3842</phone>
      <email>wejenkin@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Tatter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Devine</last_name>
      <phone>213-368-0076</phone>
      <email>karen.devine@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Andrew Sloan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Allison</last_name>
      <phone>216-444-6459</phone>
      <email>ALLISOT@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Alireza Mohammadi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsie Derr</last_name>
      <phone>570-214-2432</phone>
      <email>cmderr1@geisinger.edu</email>
    </contact>
    <investigator>
      <last_name>Michel Lacroix, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Dougherty</last_name>
      <phone>215-955-7962</phone>
      <email>Jaime.Dougherty@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Judy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madison Remick</last_name>
      <phone>216-407-1651</phone>
      <email>mar355@pitt.edu</email>
    </contact>
    <investigator>
      <last_name>Taylor Abel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Thomas West Hospital and Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Serfass, RN</last_name>
      <phone>615-222-3852</phone>
      <email>mserfass@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Steven Abram, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kalil Abdullah, MD</last_name>
      <phone>215-603-6019</phone>
      <email>Kalil.Abdullah@UTSouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Kalil Abdullah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MD Anderson</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Jacobs</last_name>
      <phone>713-745-3246</phone>
      <email>cjacobs@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Ganesh Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Procedural Success</keyword>
  <keyword>Progression</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Seizure Freedom</keyword>
  <keyword>Progression Free Survival</keyword>
  <keyword>Overall Survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

